Ikarovec Company

Ikarovec is a pre-clinical phase gene therapy company. Our programmes are aimed at treating common eye diseases, restoring sight and preventing blindness.

Last Funding Type: Seed
Funding Status: Seed
Headquarters: Cambridge, Cambridgeshire, United Kingdom
Founded Date: 2018-01-01
Last Funding Date: 2020-02-05
Total Funding: 3249285
Employee Number: 1-10
Investors Number: 4
Industry: Anti-aging Therapies